Argentina registry for people with Crohn's disease and ulcerative colitis.

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

RADECCU is a national, observational registry that captures standardized demographic, clinical, diagnostic, treatment, and outcome data from pediatric and adult patients with Crohn's disease or ulcerative colitis treated by members of the Argentine Crohn's and Ulcerative Colitis Group (GADECCU). Data are entered into a web platform supported by a technical team and managed by an executive, scientific, and methodological committee. The registry records safety events (including infections), access-to-care measures, and treatment effectiveness outcomes such as flares, hospitalizations, and surgeries. Each participating center obtained local ethics approval and follows applicable regulatory and data protection requirements.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Any patient diagnosed with IBD defined by validated diagnostic criteria can be included into the registry. The criteria for IBD diagnosis were based on previously published criteria for IBD diagnosis, including clinical, endoscopic, laboratory, and histopathological aspects, as well as small bowel imaging studies

Exclusion Criteria:

* Suspected IBD diagnosis without confirmation
* IBD patients with incomplete information about therapy and follow-up

Where it's running

• Hospital Privado Universitario de Cordoba
  Córdoba, Córdoba Province, Argentina Recruiting

Study contacts

• Principal investigator: Domingo C Balderramo, MD, PhD — Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• DISC-0974-201 for adults with IBD-related anemia

  This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.

  Recruiting at 15 sites Phase 2 Disc Medicine, Inc · Birmingham, Alabama and 14 other locations · NCT07368972

• Moderate breathing and movement: Can regular exercise help people with quiescent inflammatory bowel disease feel better?

  This trial tests whether a moderate-intensity exercise program improves quality of life for adults with Crohn's disease or ulcerative colitis who are currently in clinical remission.

  Recruiting Mahidol University · Bangkok Noi, Bangkok · NCT07775794

• Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis in Remission

  This study tests whether a Mediterranean diet, with or without an 8-hour eating window, helps gut health and quality of life in adults with ulcerative colitis in remission.

  Recruiting Pontificia Universidad Catolica de Chile · Santiago, Santiago Metropolitan · NCT07752446

• Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk

  This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.

  Recruiting Jena University Hospital · Jena · NCT07716488

• Wearable data to spot IBD flareups in people with ulcerative colitis or Crohn's disease

  This study tests whether heart‑rate variability from participants’ own wearables can help predict IBD flares.

  Recruiting at 2 sites Maastricht University Medical Center · 's-Hertogenbosch and 2 other locations · NCT07647640

• PVT401 in healthy adults

  This trial will test intravenous PVT401 in healthy adults who carry the HLA DRB4*0101 or DRB4*0103 allele to see how the drug behaves in the body and whether single and multiple doses are safe.

  Recruiting Phase 1 Parvus Therapeutics, Inc. · Melbourne, Victoria · NCT07423000

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.